Today's Clinical Lab - News, Editorial and Products for the Clinical Laboratory
Illustration of a coronavirus viral particle floating in the blood

Early SARS-CoV-2 Specific T Cell Response May Prevent Severe Infection

New research suggests SARS-CoV-2 specific T cells play an important role in the rapid control of viral infection

Duke-NUS Medical School
Published:Feb 01, 2021
|2 min read

Humoral and cellular adaptive immunity are two immune mechanisms that act against pathogens. Humoral immunity is mediated by antibodies, while cellular immunity does not involve antibodies and is, instead, facilitated by T cells. Studying how these immune mechanisms mediate SARS-CoV-2 infections could be beneficial in controlling the progression of the disease. However, their roles in viral control or disease pathogenesis are not fully understood and only a few studies have thoroughly monitored COVID-19 patients longitudinally, especially during the acute phase of infection.

To fill this knowledge gap, the team of researchers at Duke–NUS Medical School investigated the changes in virological and immunological parameters in 12 patients with symptomatic acute SARS-CoV-2 infection from onset of the disease to recovery or death. Their results were recently published in Cell Reports.

"We found that patients who control SARS-CoV-2 infection with only mild symptoms are characterized by an early induction of IFN-γ secreting SARS-CoV-2 specific T cells. The amount of humoral response, however, does not predict the level of COVID-19 disease severity," said Dr. Anthony Tanoto Tan, senior research fellow at the Duke–NUS Emerging Infectious Diseases (EID) Programme and the co-author of this study.

Related Article: T Cells Mount Attacks against Many SARS-CoV-2 Targets—Including New Variant

"Our data supports the idea that SARS-CoV-2 specific T cells play an important role in the rapid control of viral infection and eventual clearance of the disease," added Dr. Martin Linster, senior research fellow with Duke–NUS's EID Programme and the co-author of this study.

This work is a continuation of the team's previous publication in Nature, where they analyzed the SARS-CoV-2 specific T cell response in COVID-19 patients at convalescence. In this study, they have expanded the analysis to the full timeline of SARS-CoV-2 infection from onset to outcome.

"It is time that T cell monitoring should be considered in providing a comprehensive understanding of the immune response against SARS-CoV-2. This would also mean that a vaccine will likely be more effective if a holistic induction of both antibodies and T cells occurs," said professor Antonio Bertoletti, from Duke–NUS's EID Programme, who is the corresponding author of this study.

"This important study furthers our understanding of the immune response against SARS-CoV-2. It has far-reaching implications including on COVID-19 vaccine design and the subsequent monitoring of vaccine response," said professor Patrick Casey, senior vice-dean for research at Duke–NUS.

The team is now studying more symptomatic COVID-19 patients with varying disease severity to further validate their findings.

- This press release was provided by Duke–NUS Medical School